CORT MEXC RealStocks
Own real CORT shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-13 08:15:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Corcept Therapeutics Inc. (CORT) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $73.70, with a market capitalization of $8.06B and a P/E ratio of 49.76. Over the past 52 weeks, its price has ranged from $28.66 to $126.38. This page covers its latest market performance, valuation, price trends and company information.
$8.06B | |
$72.23 | |
$75.53 | |
$72.23 | |
$74.53 | |
700.14K | |
1.25M | |
49.76 | |
$126.38 | |
$28.66 | |
-- | |
-- |
Corcept Therapeutics Inc. (CORT) last closed at $73.70 as of 2026-11-13 00:31:00, down 1.06% ($0.79) from the previous close of $74.53.
During the latest regular trading session, CORT traded between $72.23 and $75.53, with a volume of 700.14K shares. The closing price was near the middle and near the middle of its 52-week range.
Over the past seven days, Corcept Therapeutics Inc. (CORT) moved from $79.22 to $73.70, representing a decline of 6.97% ($5.52).
The stock traded between $70.51 and $84.98 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.44 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 46.1%
CORT is currently trading at $73.70, placing it 46.1% of the way from its 52-week low of $28.66 to its 52-week high of $126.38. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 730 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Corcept Therapeutics Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of Corcept Therapeutics Inc. (CORT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to CORT, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between CORT shares and USD.
CORT Shares to USD
1.00 CORT shares = 73.702 USD
Calculations are estimates based on the latest available price and are for reference only.